This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tournier, J.-M. Articles by Birembaut, P. Search for Related Content PubMed PubMed Citation Articles by Tournier, J.-M. Articles by Birembaut, P.

(American Journal of Pathology. 2006;168:55-68.)
© 2006 American Society for Investigative Pathology

35ß2-Nicotinic Acetylcholine Receptor Contributes to the Wound Repair of the Respiratory Epithelium by Modulating Intracellular Calcium in Migrating Cells

Jean-Marie Tournier^*, Kamel Maouche^*, Christelle Coraux^*, Jean-Marie Zahm^*, Isabelle Cloëz-Tayarani, Béatrice Nawrocki-Raby^*, Arnaud Bonnomet^*, Henriette Burlet^*, François Lebargy^*, Myriam Polette^* and Philippe Birembaut^*

From INSERM UMRS-514,^* IFR53, Université de Reims, Reims; Unité de Biologie Cellulaire, Laboratoire Pol Bouin, and Service de Pneumologie, CHU de Reims, Reims; and Unité Récepteurs et Cognition, CNRS URA-2182, Institut Pasteur Paris, Paris, France

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
Nicotinic acetylcholine receptors (nAChRs), present in human bronchial epithelial cells (HBECs), have been shown in vitro to modulate cell shape. Because cell spreading and migration are important mechanisms involved in the repair of the bronchial epithelium, we investigated the potential role of nAChRs in the wound repair of the bronchial epithelium. In vivo and in vitro, 35ß2-nAChRs accumulated in migrating HBECs involved in repairing a wound, whereas 7-nAChRs were predominantly observed in stationary confluent cells. Wound repair was improved in the presence of nAChR agonists, nicotine, and acetylcholine, and delayed in the presence of 3ß2 neuronal nAChR antagonists, mecamylamine, -conotoxin MII, and -bungarotoxin; -bungarotoxin, an antagonist of 7-nAChR, had no effect. Addition of nicotine to a repairing wound resulted in a dose-dependent transient increase of intracellular calcium in migrating cells that line the wound edge. Mecamylamine and -bungarotoxin inhibited both the cell-migration speed and the nicotine-induced intracellular calcium increase in wound-repairing migrating cells in vitro. On the contrary -bungarotoxin had no significant effect on migrating cells. These results suggest that 35ß2-nAChRs actively contribute to the wound repair process of the respiratory epithelium by modulating intracellular calcium in wound-repairing migrating cells.

Among the numerous cellular and molecular factors involved in cell migration, nicotinic acetylcholine receptors (nAChRs) have been shown to positively or negatively regulate cell migration. The nAChRs are a family of ionotropic receptor proteins formed by five /ß homologous or five identical subunits.⁴ Cells from the surface bronchial epithelium have been shown to contain 3, 4, 5, 7, ß2, and ß4 subunits of nAChRs.^5-8 Patch-clamp experiments demonstrated that human bronchial epithelial cells (HBECs) in culture expressed functional nAChRs with ion-gating properties similar to those of nAChRs formed by 3, 5, and ß2 or ß4 subunits, also referred to as the 3ß2-nAChRs.^4,6 In addition, HBECs express the 7-nAChR.⁷ These nAChRs mediate the effects of endogenous acetylcholine (ACh) and exogenous nicotine.

It is now established that ACh may function as an autocrine or paracrine signaling molecule in a variety of nonneuronal tissues.^9,10 ACh is synthesized and secreted by airway bronchial epithelial cells.⁸ These cells contain all of the components for a nonneuronal autocrine/paracrine cholinergic loop: the choline high-affinity transporter, which allows choline to enter the cells; the enzyme choline acetyltransferase, which synthesizes ACh from free cytosolic choline and acetylcoenzyme A; and the vesicular ACh transporter, which packages ACh into vesicles in neurons¹¹ but whose role in HBECs remains to be established.^8-10 Cultures of HBECs also confirm the synthesis and secretion of ACh and the activity of cholinesterases that degrade ACh.⁸

ACh and/or nicotine regulate bronchial epithelial cell^5,6 and keratinocyte^12,13 adhesion; are chemotactic for pulmonary neutrophils,¹⁴ vascular smooth muscle cells,¹⁵ and spermatozoa;¹⁶ regulate neurite outgrowth and motility;^17,18 inhibit keratinocyte¹⁹ or cerebellar granule cell migration;²⁰ or have no effect on gastric epithelial cell²¹ or breast carcinoma cell²² migration. Different nAChRs may play opposing roles in nicotinergic control of cell migration. For example, 3- and 7-nAChRs regulate keratinocyte chemokinesis and chemotaxis, respectively, with nicotine inhibiting random migration but stimulating directional migration.²³

When exposed to mecamylamine, a noncompetitive nAChR antagonist that more efficiently blocks /ß heteromers than 7-nAChR,²⁴ or to -bungarotoxin, a selective and slowly reversible antagonist of 3/ß2-nAChR,²⁵ HBECs in culture progressively shrink, detach their flat cytoplasmic extensions from the underlying extracellular matrix, and detach from neighboring cells, effects that are reversed after removing the antagonists from the culture medium.^5,6 Because of such findings and because modifications of cell-cell and cell-extracellular matrix contacts contribute to cell migration, we investigated the potential role of nAChRs during HBEC migration and wound repair of the human bronchial epithelium.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Source of Bronchial Tissue

Human bronchial tissues from patients (mean ± SD; age, 69 ± 5 years; range, 48 to 84 years) undergoing surgery for bronchial carcinoma were obtained from microscopically normal areas distant from the tumor. Immediately after excision, the samples were immersed in Ham F-12/Dulbecco’s modified Eagle’s medium (1/3, v/v) (Gibco BRL, Paisley, Scotland) supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin (Gibco), and 25 µg/ml gentamicin (Sigma Aldrich Chimie, L’Isle d’Abeau Chesnes, France). Specimens were then either processed for cell isolation or for an ex vivo wound repair model.

Cell Culture

HBECs were isolated and cultured as previously described with some modifications.²⁶ Briefly, the bronchial tissues were digested overnight at 4°C with 0.1% Pronase E, and dissociated cells were resuspended in culture medium, which consisted of Ham F-12/Dulbecco’s modified Eagle’s medium (1/3, v/v) supplemented with 0.87 µmol/L bovine insulin, 65 nmol/L human transferrin, 1.6 nmol/L recombinant human epidermal growth factor, 1.38 µmol/L hydrocortisone, 30 nmol/L retinyl acetate, 9.7 nmol/L 3,3',5-triiodo-L-thyronine, 2.7 µmol/L (–)epinephrine, 35 µg/ml bovine pituitary extract, 5 µmol/L ethanolamine, 5 µmol/L o-phosphorylethanolamine, 30 nmol/L sodium selenite, 1 nmol/L manganese chloride, 0.5 µmol/L sodium metasilicate, 1 nmol/L ammonium molybdate, 5 nmol/L ammonium vanadate, 1 nmol/L nickel sulfate, 0.5 nmol/L stannous chloride, 100 U/ml penicillin, and 100 µg/ml streptomycin (all reagents from Sigma), as previously described.²⁷ Isolated cells were either seeded on four-well Lab-Tek II chambered coverglasses (Nalge Nunc, Naperville, IL) to study cell migration or intracellular calcium on 12-well plates (Beckton Dickinson, Le Pont de Claix, France) to evaluate wound repair index, or on 18-mm glass coverslides (VWR Int., Fontenay-sous-Bois, France) for immunocytochemistry. All culture surfaces were coated with rat tail type I collagen and prepared in the presence of 0.25 µg/ml carbodiimide as previously described.²⁶ Fetal calf serum (10%) was added to the culture medium during the first 15 hours after seeding to facilitate cell adhesion. Cells were cultured at 37°C in a humidified incubator in the presence of 5% CO₂ and 95% air. Confluent primary cultures of HBECs were generally obtained after 1 to 2 days.

Wound Repair Models

In Vitro Wound Repair Model

Primary cultures of confluent HBECs were locally injured by depositing a 1-µl drop of 1 mol/L sodium hydroxide at the center of the culture as previously described.²⁶ Sodium hydroxide was rapidly neutralized with phosphate-buffered saline (PBS) and a circular wound area of 30 mm² resulted from the sodium hydroxide-induced cellular lysis. Evolution of the remaining sur-face of the wound area was examined every day with an SMZ-U binocular microscope (Nikon France, Champigny-sur-Marne, France), and the corresponding wound area was calculated using a graphic table and the Scion Image software program (National Institutes of Health, Bethesda, MD). The linear relationship between the wound surface and time was used to calculate a wound repair index, corresponding to the decrease in wound surface per hour. When the wound had repaired 30 to 60% of its initial surface (1 to 2 days), cultures were then processed for the measurement of cell migration, intracellular calcium concentration, or immunofluorescence labeling studies as follows. Before fixation, HBEC cultures were rapidly washed in PBS. Cultures were then either fixed for 10 minutes in methanol at –20°C or sequentially fixed for 5 minutes in 3.7% paraformaldehyde in PBS, washed in PBS, incubated for 5 minutes in 0.1 mol/L glycine in PBS, washed in PBS, permeabilized for 1 minute with 0.5% Triton X-100, rinsed in PBS, and stored at 4°C until used.

Ex Vivo Wound Repair Model

Freshly collected human bronchial tissue samples, 10 x 10 mm, were locally injured with a metallic probe (2 mm in diameter), frozen with liquid nitrogen, and applied for 10 seconds to the tissue sample with a calibrated pressure of 33 kPa. Under these conditions, only cells of the surface epithelium were damaged and desquamated. In a previous study, we observed that the basement membrane in the wound area remains intact, as demonstrated by the presence of immunoreactive laminin and type IV collagen as a continuous thin layer in the damaged area.²⁸ After wound induction, tissue samples were maintained in culture for 1 to 2 days in culture medium. After 1 day in culture, the epithelial cells migrated to the wound edge to begin repair, appearing as flat cells.^28,29 At that time, cultures were fixed for 1 hour at 4°C in 4% paraformaldehyde in PBS, incubated 1 hour in 5% sucrose in PBS, 1 hour in 10% sucrose, 15 hours in 20% sucrose, embedded in Tissue Tek OCT compound (Sakura, Zoeterwoude, The Netherlands), and frozen in liquid nitrogen.

Cell Migration Quantification

After wound induction, the wounded culture was placed in a small transparent culture chamber of an IM35 inverted microscope (Zeiss, Oberkochen, Germany). Phase contrast micrographs of repairing cultures focused at the wound edge were taken at regular intervals. The images were digitized as 512 x 512 pixels and 8-bit array using a Sparc-Classic (Sun Microsystems, Mountain View, CA) workstation equipped with an XVideo card (Parallax Graphics, Santa Clara, CA). Cell migration was quantified using a previously described software³⁰ with three main functions: the detection of cell nuclei, the computation of the trajectories of these nuclei, and the analysis of these trajectories. From the trajectory of each nucleus, the computer calculated the cell migration speed.

When analyzing the effect of nAChR agonists or antagonists (nicotine, ACh, mecamylamine, and -bungarotoxin from Sigma; -conotoxin MII synthesized by Genepep, Montpellier, France; -bungarotoxin from Biotoxin Inc., St. Cloud, France) on HBEC migration, we restricted migration assessment to a population of cells located close to the edge of the wound, ie, within a distance corresponding to approximately one to two cells starting from the edge of the wound. Indeed, we previously observed that cell migration speed progressively decreases as the distance of the cells from the wound edge increases.³⁰

Immunocytochemistry

Sections of frozen bronchial tissues were cut (5 µm thick) at –20°C in a 2800 Frigocut cryostat (Cambridge Instruments, Nussloch, Germany) and transferred to gelatin-coated slides. Tissue sections and HBEC cultures undergoing repair were immunoreacted with specific polyclonal (Ab) or monoclonal (mAb) antibodies using an indirect immunofluorescence labeling technique. All incubations were conducted at room temperature.

The following antibodies were used to localize nAChR subunits and choline acetyltransferase in repairing bronchial tissues or HBEC cultures: rat mAb-210 (1,3,5; 10 µg/ml) mAb-268 (5, 10 µg/ml), and mAb-290 (ß2, 10 µg/ml) from Sigma; mouse mAb-8A4 (4, 1:40; Novocastra Laboratories, Newcastle on Tyne, UK); goat C-18-Ab (3, 10 µg/ml), D-19-Ab (5, 10 µg/ml), C-20-Ab (ß2, 5 µg/ml), and rabbit H-302-Ab (7, 10 µg/ml), all from Santa Cruz Biotechnology, Santa Cruz, CA; and mouse mAb-5270 (choline acetyltransferase, 20 µg/ml; Chemicon, Temecula, CA). Nonspecific binding was blocked for 30 minutes with 3% bovine serum albumin (BSA) in PBS. The samples were then incubated for 60 minutes with the primary antibodies prepared in 1% BSA in PBS (PBS-BSA). After two washes in PBS for 5 minutes, and one wash in PBS-BSA for 5 minutes, the samples were incubated with biotinylated secondary antibodies (Jackson ImmunoResearch, West Grove, PA) diluted 1/100 in PBS-BSA for 60 minutes and then incubated with Alexa 488-streptavidin (Molecular Probes, Eugene, OR) diluted 1/50 in PBS for 30 minutes. We verified the absence of cross-reactivity by incubating control cultures and tissue sections with nonimmune IgG instead of the primary antibody. After immunolabeling, cultures were counterstained with Harris hematoxylin (Diagnostica Merck, Darmstadt, Germany) and mounted in Citifluor anti-fading solution (Agar Scientific, Essex, UK). All fluorescence-labeled preparations were examined with an Axiophot microscope (Zeiss) using successive epifluorescence and Nomarski differential interference illumination.

Identification of [¹²⁵I]-Epibatidine Binding Sites in the Bronchial Epithelium

Sections of frozen bronchial tissues were cut (20 µm thick) at –20°C, transferred to SuperFrost Plus slides (Kindler, Freiburg, Germany), and kept at –20°C until use. Sections were incubated at room temperature with 200 pmol/L [¹²⁵I]-epibatidine (specific activity 2200 Ci/mmol; Perkin Elmer, Boston, MA) in 50 mmol/L Tris, pH 7.4, for 30 minutes. After incubation, sections were rinsed twice for 5 minutes in the same buffer and briefly in ice-cold distilled water. Nonspecific binding was measured in the presence of 1 mmol/L nicotine. Sections were then exposed to Kodak Biomax films (Kodak Pathé, Paris, France) for 80 hours. Sections were stained using carbol toluidine blue (Réactifs RAL, Martillac, France).

Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analyses

RNA was extracted from migrating HBECs with High Pure RNA isolation kit as recommended by the manufacturer (Roche Diagnostics GmbH, Mannheim, Germany). RNA concentrations were measured with the Ribogreen kit (Molecular Probes). RT-PCR was performed with 10 ng of total RNA by using the Thermostable rTth Reverse Transcriptase RNA PCR kit (Applied Biosystems, Foster City, CA). Primers were designed to amplify specific members of the nAChR gene family using GenBank sequences or previously designed primers as mentioned. Their sequences and expected product size (in parentheses) were as follows: 3, 5'-AGCAACGAGGGCAACGCTCAGAA-3' and 5'-CAGAACTAGAGCTTCTCGTGAGGT-3' (195 bp); 4, 5'-TGGGTGAAGCAGGAGAGTGG-3' and 5'-AGTCCAGCTGGTCCACG-3' (346 bp);⁶ 5, 5'-GTGGTAGTGGACCAAAATCTTCTA-3' and 5'-GCCCAAGA-GATCCAACAATTGAAA-3' (191 bp); 7, 5'-CAGTCTTACTCTCTCTTACCGTCT-3' and 5'-GCACCAGTTCA-GAAGGATGACTC-3' (217 bp); ß2, 5'-CAGCTCATCAG-TGTGCA-3' and 5'-GTGCGGTCGTAGGTCCA-3' (347 bp);¹² and ß4, 5'-TCGATGTGCCTCTCATCGGCAA-3' and 5'-GCTTGGTCACGCATGACTTGCT-3' (239 bp). All PCR products were verified by sequencing (SeqLab, Göttingen, Germany).

Measurement of [Ca²⁺]_i

The concentration of [Ca²⁺]_i in migrating HBECs was measured with the calcium-sensitive Fura-2 acetoxymethyl ester by the fluorescence ratiometric method with modifications.⁵ Cells were cultured in four-well Lab-Tek II chambered coverglasses, were loaded with 3 µmol/L Fura-2 (Molecular Probes) in culture medium containing 20 mmol/L HEPES for 60 minutes, washed in the same medium, and allowed to recover in a 5% CO₂ incubator at 37°C for 60 minutes. The chamber slide was placed on the preheated stage (37°C) of an inverted Nikon TE300 microscope equipped with an incubator chamber. The Fura-2 fluorochrome was excited every 10 or 20 seconds and sequentially at wavelengths of 340 and 380 nm generated by a Polychrome II monochromator (TILL Photonics, Planegg, Germany); the emission at 510 nm was detected with a x40 Plan Fluor objective (Nikon) and a cooled charge-coupled device camera (Micromax; Roper Scientific, Evry, France). In all experiments, increments of [Ca²⁺]_i evoke a positive signal at 340 nm and a negative signal at 380 nm. The wavelengths of excitation and emission, the time course of image acquisition, and the image treatment were controlled by the computer software Metafluor (Universal Imaging, West Chester, PA). The fluorescence was quantified by averaging pixel intensities in the area of interest and by subtracting background fluorescence, corresponding to a wound area devoid of cells.

For [Ca²⁺]_i calculations, R = F₃₄₀/F₃₈₀, R_min (0% saturation of the dye with Ca²⁺) and R_max (100% sat-uration with Ca²⁺) were determined. At the end of each acquisition, R_max was obtained by adding 5 µmol/L ionomycin (Sigma) to the culture medium, and R_min was obtained after removing ionomycin, washing the cells with culture medium, and incubating the cells for 10 minutes in 5 mmol/L EGTA (Sigma). R, R_max, and R_min were calculated from image acquisitions derived from the same group of cells and the same background area. [Ca²⁺]_i was calculated with the following equation: [Ca²⁺]_i = K_D x F_min/F_max x [(R – R_min)/(R_max – R)], where R is the fluorescent ratio, R_max is the maximum ratio value, and F_max is F₃₈₀ measured at high [Ca²⁺]_i in the presence of 5 µmol/L ionomycin, and R_min is the minimum ratio value, and F_min is F₃₈₀ measured at low [Ca²⁺]_i in the presence of 5 mmol/L EGTA, and K_D is the dissociation constant of the Ca²⁺ binding to Fura-2 (224 nmol/L).³¹

Immunoprecipitation and Western Blotting

Proteins in migrating HBECs present in cultures derived from four different bronchial samples were extracted in RIPA buffer [50 mmol/L Tris, pH 7.4, 150 mmol/L NaCl, 1% Igepal (v/v), 1% sodium deoxycholate (w/v), 0.1% sodium dodecylsulfate (w/v)] containing complete protease inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany). Lysates were pooled and cleared by spinning at 12,500 x g for 10 minutes. Protein concentrations were determined with the BCA protein assay reagent (Pierce, Rockford, IL). Proteins were preincubated with protein G-Sepharose CL-4B beads (Amersham Biosciences, Saclay, France) by rocking 1 hour at 4°C. These beads were discarded, and the supernatant (500 µg protein) was incubated with 1 µg of one of the following goat polyclonal nAChR-specific antibodies (C-18-Ab to 3, D-19-Ab to 5, or C-20-Ab to ß2) or 1 µg control IgG for 3 hours on a rotating wheel at 4°C. Protein G-Sepharose beads were then added, and the samples were incubated for 1 hour at 4°C. Beads were washed six times in lysis buffer and boiled in Laemmli sample buffer, and proteins were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels under reducing conditions using the Bio-Rad Mini-PROTEAN II electrophoresis system (Bio-Rad, Hercules, CA) and transferred to Immobilon polyvinylidene difluoride membrane (Millipore) using the Bio-Rad Mini Trans-Blot system. Blots were incubated for 1 hour in blocking buffer (5% low-fat milk powder, 0.1% Tween-20 in PBS) and then incubated overnight at 4°C with one of the following antibodies diluted in blocking buffer: mAb-210 (1,3,5), mAb-268 (5), or mAb-290 (ß2). The membranes were incubated with a horseradish peroxidase-conjugated rabbit anti-rat antibody (DAKO, Glostrup, Denmark). Signal was detected with ECL+ kit (Amersham Biosciences) and quantified with a Las-1000+ camera (Raytest France, Courbevoie, France).

	Results

Top Abstract Materials and Methods Results Discussion References

 
35ß2-nAChRs Are Overexpressed in Migrating HBECs

We studied the distribution of nAChRs in ex vivo epithelia undergoing repair. In normal pseudostratified epithelium located away from the wound, nAChRs could be detected with both the anti-1,3,5 mAb-210 and the anti-ß2 mAb-290 antibody in the basal layer of the epithelium (Figure 1) . These basal cells were weakly labeled by the antibodies compared to epithelial cells migrating to cover the wounded area. Cells that were positive for 1,3,5 and ß2 subunits, both in the normal epithelium and in migrating cells, could be identified as basal cells as a result of their immunoreactivity for antibodies specific for cytokeratins 13 and 14 (data not shown). At the lesion edge, we observed the transition between the thick pseudostratified epithelium and the flat epithelial layer spreading over the denuded wounded surface. In this transition region, flat migrating basal cells were more intensely labeled for the presence of nAChRs than cuboidal basal cells in normal epithelium. High magnification of ß2 subunit labeling revealed that ß2 was distributed both in the cytoplasm and at the cell surface in basal cells, suggesting that the mAb-290 antibody recognized both immature cytoplasmic and mature membranous forms of ß2-nAChRs (Figure 2, A and B) . Immunoreactivity for ß2-nAChRs was observed essentially in basal cells of the surface bronchial epithelium, with some peripheral glandular cells in the submucosa also weakly labeled (Figure 2, F and G) . Epibatidine is a potent nicotinic agonist with high affinity for human 3ß2- and 3ß4-nAChRs.³² When used at a 200 pmol/L concentration, [¹²⁵I]-epibatidine binds to the cells present at the surface of bronchial epithelium (Figure 2C) . The binding of epibatidine was abolished in the presence of 1 mmol/L nicotine (Figure 2E) .

View larger version (98K): [in this window] [in a new window]   Figure 1. Identification of nicotinic receptors in repairing bronchial tissues. Normal human epithelium was locally wounded and maintained in culture for 1 day as described in Materials and Methods. The localization of nAChRs was studied by immunofluorescence using the rat mAb-210, specific for the 1, 3, and 5 subunits (top), or the rat mAb-290 monoclonal antibody, specific for the ß2 subunit (bottom), with Alexa Fluor 488 conjugate (green color in dark panels). Left column: Stationary cells in the unwounded pseudostratified normal epithelium. Middle column: Migrating cells in the wounded area. Right column: Transition area between the normal unwounded epithelium and the migrating cells. Scale bars, 20 µm.

View larger version (98K): [in this window] [in a new window]   Figure 2. Localization of ß2-nAChRs and of binding sites for [125I]-epibatidine in the bronchial epithelium. The localization of the ß2 subunit of nAChRs was evaluated using an immunofluorescent labeling technique with the mAb-290 antibody in 5-µm-thick (A and B) or 20-µm-thick (F and G) sections of human bronchial tissues. Binding sites for epibatidine were identified in 20-µm-thick sections in the absence (C) or presence (E) of 1 mmol/L nicotine, as described in Materials and Methods. C, E, and F correspond to serial 20-µm sections of the same bronchial tissue. A, D, and G depict hematoxylin (A and G) or toluidine blue (D) staining of sections corresponding to immunofluorescence or autoradiography presented in B, C, and F, respectively. SE, surface epithelium; Gl, submucosal glands; Ca, cartilage. Scale bars: 10 µm (A, B); 1 mm (C–E); or 100 µm (F, G).

View larger version (64K): [in this window] [in a new window]   Figure 3. Identification of nAChRs and choline acetyltransferase in repairing HBEC cultures. One day after injuring primary cultures of HBECs, cultures were fixed and evaluated, using immunofluorescent labeling techniques with Alexa Fluor 488 conjugates, for the distribution of nAChR subunits with the following antibodies: C-18-Ab for 3 subunit (A), mAb-8A4 for 4 subunit (B and C), D-19-Ab for 5 subunit (D), H-302-Ab for 7 subunit (E and F), mAb-210 for 1,3,5 subunits (G), mAb-290 for ß2 subunit (H). The presence of choline acetyltransferase (CHAT) was also evaluated with the mAb-5270 (I). Micrographs correspond to the edge of the wounds (A, B, D, E, G–I) or to stationary cells in the unwounded area (C and F). Arrows in F point to ciliated cells. Scale bars: 50 µm (A, D, H); 25 µm (B, C, E–G, and I).

View larger version (74K): [in this window] [in a new window]   Figure 4. Immunoblot analysis showing that ß2 associates with 3 and 5 subunits of nAChRs in migrating HBECs. Nicotinic receptors were solubilized in RIPA buffer from migrating HBECs in culture and immunopurified from cell extracts with the following antibodies: goat C-18-Ab for 3 subunit, goat D-19-Ab for 5 subunit, goat C-20-Ab for ß2 subunit, control goat IgG, or in absence of antibody (no IgG). Samples were analyzed by immunoblot technique for their reactivity with the following rat monoclonal antibodies: mAb-210 for 1,3,5 subunits, mAb-268 for 5 subunit, and mAb-290 for ß2 subunit, as described in Materials and Methods. Molecular weights of standard proteins (Bio-Rad) have been reported on the right.

View larger version (51K): [in this window] [in a new window]   Figure 5. Detection of 3, 5, 7, ß2, and ß4 subunit transcripts of nAChRs in cultured HBECs by RT-PCR. RT-PCR experiments were performed using RNA extracted from migrating HBECs in culture and primers specific for the different neuronal nAChR subunits, as indicated. The positions of a 100-bp ladder are reported on the right.

The in Vitro Wound Repair of the Bronchial Epithelium Is Modulated by Agonists and Antagonists of 35ß2-nAChRs

Because 35ß2-nAChRs were more markedly identified in HBECs when they migrated to repair a wound in both ex vivo and in vitro models, we hypothesized that nAChRs were involved in the wound repair process. We tested whether a modulation of nAChR activity, by agonists or antagonists, influenced the wound repair process. By using an in vitro model of bronchial epithelium wound repair, we quantified the speed of the wound closure in the presence of nAChR agonists (nicotine and ACh) or antagonists (mecamylamine, a noncompetitive reversible antagonist of /ß heteromer nAChRs; -bungarotoxin, a highly selective antagonist of 7-nAChR;³⁴ -conotoxin MII, a highly selective antagonist of the 3ß2-nAChRs;^35,36 and -bungarotoxin, a selective and slowly reversible antagonist of 3ß2 neuronal nAChRs³⁷ ). After a 15 hour-exposure to 1 mmol/L nicotine or ACh, we observed a more rapid wound closure; however, the wound repair speed was reduced in the presence of 1 mmol/L mecamylamine or 1 µmol/L -bungarotoxin (Figure 6 , micrographs in A). The wound repair index increased in the presence of 10^–5 to 10^–3 mol/L nicotine (10^–5 mol/L: +9.6%, P = 0.0389; 10^–4 mol/L: +18%, P = 0.0201; 10^–3 mol/L: +25.2%, P = 0.0201) or ACh (10^–5 mol/L: +14.6%, P = 0.0201; 10^–4 mol/L: +23.6%, P = 0.0201; 10^–3 mol/L: +34.6%, P = 0.0201). The wound repair index was decreased in the presence of 10^–5 to 10^–3 mol/L mecamylamine (10^–5 mol/L: –18%, P = 0.0201; 10^–4 mol/L: –46%, P = 0.0201; 10^–3 mol/L: –76%, P = 0.0201), in the presence of 1 or 10 µmol/L -conotoxin MII (–17%, P = 0.0201; –49%, P = 0.0201; respectively) and in the presence of 0.1 or 1 µmol/L -bungarotoxin (–38%, P = 0.0201; –73%, P = 0.0201, respectively) (Figure 6B) . Because -bungarotoxin more efficiently inhibited 35ß2-nAChR-mediated wound repair than -conotoxin MII, -bungarotoxin was preferred to -conotoxin MII in the following experiments.

View larger version (70K): [in this window] [in a new window]   Figure 6. Effect of nicotinic agonists and antagonists on the wound repair of HBECs in culture. Immediately after wounding, primary HBEC cultures were exposed for 15 hours to different concentrations (10–7 to 10–3 mol/L) of nicotinic receptor agonists (nicotine and ACh) or antagonists (mecamylamine, -bungarotoxin, -conotoxin MII, and -bungarotoxin). The wound repair index was then calculated for each condition, as described in Materials and Methods. A: Phase contrast micrographs of repairing cultures at the end of the experiment in the control condition or in the presence of 1 mmol/L nicotine, 1 mmol/L ACh, 1 mmol/L mecamylamine, 10 µmol/L -bungarotoxin, or 1 µmol/L -bungarotoxin. B: During the wound repair process, the wound repair index was evaluated in each condition and compared (Mann-Whitney test) to the same parameter in the control experiment: *P < 0.05. Each condition (mean ± SD) was run in triplicates. Scale bar, 1 mm.

Antagonists of 35ß2-nAChRs Decrease the in Vitro Migration of HBECs

We quantified and studied cell migration speeds at the edge of the wound and investigated the effect of mecamylamine, -bungarotoxin, and -bungarotoxin. After exposure of cells to mecamylamine, the cell migration speed at the edge of the wound progressively declined (Figure 7A) , the effect of mecamylamine being dose- and time-dependent (Figure 7B) . After a 1-hour exposure to 1 mmol/L mecamylamine, we observed a 55% decrease in the cell migration speed. The effect of mecamylamine was reversible as cells rapidly returned to a normal migration speed after mecamylamine was removed from the culture medium (Figure 7C) . In the presence of 1 µmol/L -bungarotoxin, the migration speed of the cells also progressively declined, with a 45% decrease in cell migration speed after a 1-hour exposure to -bungarotoxin. Exposure of migrating HBECs to 10 µmol/L -bungarotoxin had no significant effect on cell migration throughout a 1-hour incubation period (Figure 7D) .

View larger version (50K): [in this window] [in a new window]   Figure 7. Effect of mecamylamine, -bungarotoxin, and -bungarotoxin on HBEC migration. One day after injury of primary cultures of HBECs, cell migration was measured as described in Materials and Methods. A: Phase contrast micrograph of migrating HBECs at the beginning of the experiment and trajectories of individual cells during the control period (in white) and in the presence of 1 mmol/L mecamylamine (in black), corresponding to the values reported in B (1 mmol/L Mec). Migration speeds of the cells (n = 30) located at the edge of the wound were determined every 20 minutes (B and D) or 10 minutes (C) throughout a 60-minute (B and D) or 40-minute (C) control period. B: At 60 minutes, 0.1 mmol/L (filled triangles) or 1 mmol/L (filled diamonds) mecamylamine (+Mec) or its vehicle (culture medium, filled squares) was added to the culture medium, and the migration speeds of the same cells were monitored throughout an additional 60-minute period. C: At 40 minutes, 1 mmol/L mecamylamine (+1 mmol/L Mec) was added to the culture medium, and the migration speeds of the same cells were monitored throughout an additional 40-minute period. At 80 minutes (wash), mecamylamine was removed, cells were washed with fresh culture medium and the migration speeds of the same cells were monitored again throughout an additional 40-minute period. D: At 60 minutes, 10 µmol/L -bungarotoxin (filled triangles) or 1 µmol/L -bungarotoxin (filled diamonds) (+Bung) or their vehicle (culture medium, filled squares) were added to the culture medium, and the migration speeds of the same cells were monitored throughout an additional 60-minute period. Each bar represents the mean ± SD of the migration speed of 30 cells. Cell migration at each time and in the presence of mecamylamine, -bungarotoxin, or -bungarotoxin was compared (paired t-test) to cell migration during the control period: *P < 0.05, **P < 0.01, ***P < 0.001. Scale bar, 40 µm.

35ß2-nAChRs Modulate Intracellular Calcium in Migrating HBECs

Nicotinic receptors belong to the family of ligand-gated multisubunit ion channels, activation of which mediates the entrance of monovalent or divalent cations into the cell. Because Ca²⁺ plays a crucial role in regulating many functions in HBECs³⁸ and is involved in the regulation of cell migration,^39,40 we studied the variations in [Ca²⁺]_i in migrating HBECs on exposure to nicotine. The addition of 1 mmol/L nicotine to the medium of HBEC cultures undergoing wound repair rapidly increased [Ca²⁺]_i in migrating cells (Figure 8) . The amplitude of [Ca²⁺]_i increase was more pronounced in the cells lining the wound edge (zone 1 in Figure 8A ), with [Ca²⁺]_i rising from 50 nmol/L to 170 nmol/L. In cells located away from the wound edge, [Ca²⁺]_i did not rise greater than 70 nmol/L after the addition of nicotine (Figure 8B) . The increase in [Ca²⁺]_i was transient because it lasted 1 minute (Figure 8, B and C) . The effect of nicotine on [Ca²⁺]_i was dose-dependent because 0.5 and 1 mmol/L concentrations of nicotine elicited a progressive increase in [Ca²⁺]_i (+158%, P = 0.02 and + 281%, P = 0.02, respectively) (Figure 9, A–D) . We did not observe any significant variations in [Ca²⁺]_i on exposure with nicotine concentrations lower than 0.5 mmol/L. The effect of nicotine on [Ca²⁺]_i could be prevented by preincubating cells with 1 mmol/L mecamylamine (Figure 9E) . The effect of mecamylamine was reversible because the nicotine-induced increase in [Ca²⁺]_i in migrating cells could be partially restored after removing mecamylamine from the culture medium (Figure 10) . The nicotine-induced increase of [Ca²⁺]_i in migrating cells was completely abolished in the presence of 1 mmol/L mecamylamine (Figures 9E and 10) but did not significantly change after a 60-minute exposure to 1 or 10 µmol/L -bungarotoxin (Figure 9, F and G) . On the contrary, -bungarotoxin prevented 88% of the nicotine-induced increase of [Ca²⁺]_i in migrating cells at a 1 µmol/L concentration (Figure 9I) .

View larger version (100K): [in this window] [in a new window]   Figure 8. Nicotine increases the [Ca2+]i in migrating HBECs in culture. One day after injuring primary cultures of HBECs, cells were loaded with 3 µmol/L Fura-2 for the measurement of [Ca2+]i as described in Materials and Methods. The [Ca2+]i was recorded every 10 seconds throughout a 200-second period in three different zones as reported in A. Zone 1 corresponds to cells lining the wound edge; zones 2 and 3 correspond to the second and third lines of cells from the wound edge, respectively. The red line in A corresponds to the forefront of the cellular protrusions lining the wound edge. Arrows point at lamellipodia of three advancing cells. B: Evolution of [Ca2+]i in zones 1, 2, and 3. Nicotine (1 mmol/L) was added to the culture medium 20 seconds after the beginning of [Ca2+]i recording. C: Pseudocolor calcium ratio (340/380 nm; blue, low [Ca2+]i; yellow, high [Ca2+]i), images were taken at 10, 25, 50, 75, 100, and 150 seconds after addition of 1 mmol/L nicotine. Scale bars, 20 µm.

View larger version (18K): [in this window] [in a new window]   Figure 9. Effects of nicotine, mecamylamine, -bungarotoxin, and -bungarotoxin on the [Ca2+]i in migrating HBECs. The effects of nicotine and the nicotinic receptor antagonists mecamylamine, -bungarotoxin, and -bungarotoxin on the [Ca2+]i were studied by image analysis in migrating HBECs located at the wound edge on day 1 of the wound repair process, as described in Materials and Methods. [Ca2+]i was monitored in the absence (A) or in the presence of 0.1 mmol/L (B), 0.5 mmol/L (C), or 1 mmol/L (D) nicotine. After a 5-minute incubation with 1 mmol/L mecamylamine (E), with 0.1 µmol/L (H) or 1 µmol/L (I) -bungarotoxin, or after a 60-minute incubation with 1 µmol/L (F) or 10 µmol/L (G) -bungarotoxin, cells were challenged with 1 mmol/L nicotine during the [Ca2+]i recording. Results are expressed as mean [Ca2+]i± SD for four different experiments conducted on primary cultures of HBECs derived from four different bronchial samples. The significance of the differences between groups was determined using Mann-Whitney test.

View larger version (13K): [in this window] [in a new window]   Figure 10. Mecamylamine reversibly inhibits nicotine-induced [Ca2+]i increase in migrating HBECs in culture. The variation of nicotine-induced [Ca2+]i in migrating HBECs, located at the wound edge on day 1 of the wound repair process, was followed as described in Figure 8 . 1, Nicotine (1 mmol/L) was added to the culture medium and [Ca2+]i was monitored for 340 seconds. 2, Culture medium was removed, cells were washed, and 1 mmol/L mecamylamine was added in the culture medium. 3, Nicotine (1 mmol/L) was added to the culture medium, and [Ca2+]i was monitored for an additional 260-second period. 4, Cells were washed with the culture medium. 5, Nicotine (1 mmol/L) was added to the culture medium and [Ca2+]i was monitored for an additional 260-second period. Throughout the entire experiment, [Ca2+]i was monitored in the same group of migrating HBECs.

	Discussion

Top Abstract Materials and Methods Results Discussion References

Our results demonstrate that the 35ß2-nAChR is involved in bronchial epithelium wound repair, whereas the 7-nAChR does not seem to play any crucial role in this process. The specific antagonist of the 7-nAChR, -bungarotoxin, did not induce a significant decrease in the wound repair index, even when tested at a 10 µmol/L concentration. Contrary to the 35ß2-nAChR, the 7-nAChR was not identified in migratory HBECs but, rather, was concentrated on the lateral cell border of confluent cells located away from the wound edge. These highly packed cells were shown to be differentiated, as confirmed by the presence of numerous ciliated cells. On the other hand, wound-repairing migrating HBECs are characterized by a dedifferentiated phenotype¹ with some mesenchymal properties.²⁹ The 7-nAChR plays a central role in the late stages of keratinocyte differentiation in the epidermis by regulating expression of the cell-cycle progression, apoptosis, and terminal differentiation genes.⁴¹ In cultured keratinocytes, 7-immunoreactive cells are large immotile cells in contrast to the small highly mobile cells immunostained with the 3, 5, and ß2 antibodies.⁴² From these observations, we conclude that the 35ß2-nAChR and 7-nAChR may be involved in HBEC migration and differentiation, respectively. Recently, Chernyavsky and colleagues²³ have observed that the 3ß2-nAChR regulates in vitro the keratinocyte random migration, whereas the 7-nAChR is rather involved in the directional migration of keratinocytes against a gradient of nicotinic agonists. Similarly, 7-nAChR mediates migration of vascular smooth muscle cells toward nicotine.¹⁵ In these experiments, cells were induced to migrate according to a centrifugal random or directional movement. In our ex vivo and in vitro models of HBEC migration, bronchial tissues or confluent HBEC cultures were locally injured. This injury resulted in local cell desquamation similar to that observed in vivo in remodeled bronchial epithelia,^43-45 and the wound repair process was characterized by a uniform centripetal direction of cell movement.⁴⁶ In centrifugal models of cell migration, we observed that many cells migrated as individual cells and had random trajectories (unpublished observations), whereas in centripetal models all cells had a coordinated movement.^1,46 We performed all of the experiments described here by using freshly isolated HBECs and short-term exposures to nicotinic agonists. Our in vitro results are thus likely to be more relevant to an in vivo situation. In most other reports dealing with nAChR and cell migration, cells were chronically exposed to nicotinic agonists for up to 10 days before measurements of cell migration.^19,23 Long-term exposure to nicotine induces nAChR expression.^12,47,48 These differences both in migration models, centrifugal versus centripetal cell migration, in duration of agonist exposure and in tissue origin may explain the differences observed in the contribution of nAChRs in the migration of keratinocytes and bronchial epithelial cells.

We observed that the 35ß2-nAChR was identified, with a low level of expression compared with migrating HBECs, in the basal layer of the pseudostratified normal and stationary bronchial epithelium. The presence of 35ß2-nAChRs in the surface bronchial epithelium was confirmed by autoradiographic studies showing that [¹²⁵I]-epibatidine, a potent nicotinic agonist with high affinity for human 3ß2- and 3ß4-nAChRs,³² bound specifically to the cells present at the surface of bronchial epithelium. Similarly, keratinocytes present in the lower layers of the epidermis express 3ß2-nAChRs, which are suggested to be involved in maintaining the flat shape of the cells necessary to form a continuous layer over the epidermal basement membrane.^12,19 Because of continuous exposure to noxious inhaled agents, the airway epithelium is permanently injured and there is a continual shedding of surface epithelial cells; this requires a regenerative process that includes differentiation and proliferation.⁴⁹ The basal cells represent the major dynamic source of epithelial cells in the airway.⁵⁰ Differentiation of mature ciliated and secretory cells from basal cells requires changes in cell shape, elongation of the cells up to the airway lumen, and modifications of cell-cell and cell-extracellular matrix contacts, as in migrating repair cells. Moreover, cells that migrate to repair a wound retain some characteristics of basal cells and express cytokeratins 13 and 14.^26,29 Although this must be confirmed in future investigations, we can hypothesize that 35ß2-nAChRs involved in cell migration during wound repair may also have a role in the continuous renewal of bronchial epithelial cells.

We observed that exposure of migrating cells to nicotine induced a transient increase of intracellular calcium in cells lining the wound edge. We demonstrated the major contribution of the 35ß2-nAChR in the nicotine-induced variations of intracellular calcium in migrating HBECs. nAChRs are ligand-gated channels selective for cations.⁵¹ Because of the major role of intracellular calcium, many studies have focused on the Ca²⁺ permeability of nAChRs. The 7-nAChR has garnered much attention because it is highly permeable to Ca^2+52,53 and thus regulates many Ca²⁺-dependent cellular processes, such as cell plasticity, growth, migration, and survival.⁵¹ The 3-nAChR was initially shown to have significant Ca²⁺ permeability, but much lower than that of the 7-nAChR.^54,55 The introduction of 5 subunit in the 3ß2-nAChRs further increases Ca²⁺ permeability to values comparable to the 7-nAChR.⁵⁶ Because of the much slower desensitization rates of 3ß2-nAChRs compared with the 7-nAChR,^33,57 35ß2-nAChRs could potentially, throughout prolonged periods, conduct more Ca²⁺ than could 7-nAChRs. This suggests that 35ß2-nAChRs may play more important roles than previously suspected in ACh-induced Ca²⁺-mediated effects in nonneuronal cells. Influx of Ca²⁺ into the cell is determinant on the induction of locomotion, control of direction of locomotion, and modulation of shape of epithelial cells.^39,58 For example, intracellular Ca²⁺ concentrations correlate with leukocyte migration speed.³⁹ Our results showed that nicotine increased [Ca²⁺]_i in migrating HBECs located close to the edge of the wound. We previously observed that these cells migrated to the wounded area with the highest velocity, compared to cells located away from the wound edge.³⁰ Our results thus demonstrate that cells at the wound edge migrate with a high velocity, have an overexpression of 35ß2-nAChRs and display a high 35ß2-nAChR-dependent increase in [Ca²⁺]_i when exposed to nicotine, suggesting that 35ß2-nAChRs control HBEC migration by modulating [Ca²⁺]_i. 35ß2-nAChRs in migrating cells are likely to be stimulated by ACh produced by migrating and stationary HBECs. Indeed, we observed that all HBECs in culture contained choline acetyltransferase, which mediates ACh synthesis.

In conclusion, we have observed that the 35ß2-nAChR modulates intracellular calcium in migrating HBECs and is involved in HBEC migration and wound repair of the bronchial epithelium. Cell migration is also a determinant during fetal development and invasion of cancer cells. The role of the 35ß2-nAChR in the establishment of the bronchial epithelium and the development of bronchial invasive cancers remains to be defined.

	Footnotes

 
Address reprint requests to Jean-Marie Tournier, INSERM UMRS-514, 45 rue Cognacq-Jay, 51092 Reims Cedex, France. E-mail: jm.tournier{at}univ-reims.fr

Supported by grants from the Association pour la Recherche sur les Nicotianées, the Lions Club Villers-Cotterêts Soissons, the Association Vaincre La Mucoviscidose (to C.C.), and the Région Champagne-Ardenne (to A.B. and K.M.).

Accepted for publication August 26, 2005.

	References

Top Abstract Materials and Methods Results Discussion References

 

1. Zahm JM, Chevillard M, Puchelle E: Wound repair of human surface respiratory epithelium. Am J Respir Cell Mol Biol 1991, 5:242-248[Medline]
2. Shimizu T, Nishihara M, Kawaguchi S, Sakakura Y: Expression of phenotypic markers during regeneration of rat tracheal epithelium following mechanical injury. Am J Respir Cell Mol Biol 1994, 11:85-94[Abstract]
3. Herard AL, Zahm JM, Pierrot D, Hinnrasky J, Fuchey C, Puchelle E: Epithelial barrier integrity during in vitro wound repair of the airway epithelium. Am J Respir Cell Mol Biol 1996, 15:624-632[Abstract]
4. Galzi JL, Changeux JP: Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 1995, 34:563-582[CrossRef][Medline]
5. Zia S, Ndoye A, Nguyen VT, Grando SA: Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997, 97:243-262[Medline]
6. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX, Conti-Fine BM: Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998, 54:779-788[Abstract/Free Full Text]
7. Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM: Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 2001, 60:1201-1209[Abstract/Free Full Text]
8. Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, Spindel ER: Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004, 145:2498-2506[Abstract/Free Full Text]
9. Klapproth H, Reinheimer T, Metzen J, Munch M, Bittinger F, Kirkpatrick CJ, Hohle KD, Schemann M, Racke K, Wessler I: Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol 1997, 355:515-523[CrossRef][Medline]
10. Wessler I, Kirkpatrick CJ, Racke K: The cholinergic ‘pitfall’: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999, 26:198-205[CrossRef][Medline]
11. Erickson JD, Varoqui H, Schafer MK, Modi W, Diebler MF, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB: Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 1994, 269:21929-21932[Abstract/Free Full Text]
12. Grando SA, Horton RM, Pereira EF, Diethelm-Okita BM, George PM, Albuquerque EX, Conti-Fine BM: A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995, 105:774-781[CrossRef][Medline]
13. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Grando SA: Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 2003, 72:2081-2085[CrossRef][Medline]
14. Totti N, III, McCusker KT, Campbell EJ, Griffin GL, Senior RM: Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 1984, 223:169-171[Abstract/Free Full Text]
15. Li S, Zhao T, Xin H, Ye LH, Zhang X, Tanaka H, Nakamura A, Kohama K: Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine. J Pharmacol Sci 2004, 94:334-338[CrossRef][Medline]
16. Dwivedi C, Long NJ: Effect of cholinergic agents on human spermatozoa motility. Biochem Med Metab Biol 1989, 42:66-70[CrossRef][Medline]
17. Zheng JQ, Felder M, Connor JA, Poo MM: Turning of nerve growth cones induced by neurotransmitters. Nature 1994, 368:140-144[CrossRef][Medline]
18. Owen A, Bird M: Acetylcholine as a regulator of neurite outgrowth and motility in cultured embryonic mouse spinal cord. Neuroreport 1995, 6:2269-2272[Medline]
19. Zia S, Ndoye A, Lee TX, Webber RJ, Grando SA: Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 2000, 293:973-981[Abstract/Free Full Text]
20. Fucile S, Renzi M, Lauro C, Limatola C, Ciotti T, Eusebi F: Nicotinic cholinergic stimulation promotes survival and reduces motility of cultured rat cerebellar granule cells. Neuroscience 2004, 127:53-61[CrossRef][Medline]
21. Sato N, Watanabe S, Hirose M, Wang XE, Maehiro K, Murai T, Kobayashi O, Nagahara A, Ogihara T, Kitami N: Effect of nicotine in migration and proliferation of rabbit gastric mucosal cells in a culture cell model. J Gastroenterol Hepatol 1994, 9(Suppl 1):S66-S71
22. Drell TL, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F: Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003, 80:63-70[CrossRef][Medline]
23. Chernyavsky AI, Arredondo J, Marubio LM, Grando SA: Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J Cell Sci 2004, 117:5665-5679[Abstract/Free Full Text]
24. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC: Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 1997, 280:346-356[Abstract/Free Full Text]
25. Papke RL, Duvoisin RM, Heinemann SF: The amino terminal half of the nicotinic beta-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin. Proc R Soc Lond B Biol Sci 1993, 252:141-148[Medline]
26. Buisson AC, Zahm JM, Polette M, Pierrot D, Bellon G, Puchelle E, Birembaut P, Tournier JM: Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J Cell Physiol 1996, 166:413-426[CrossRef][Medline]
27. Lechner JF, LaVeck MA: A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Methods 1985, 9:43-48[Medline]
28. Legrand C, Gilles C, Zahm JM, Polette M, Buisson AC, Kaplan H, Birembaut P, Tournier JM: Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J Cell Biol 1999, 146:517-529[Abstract/Free Full Text]
29. Buisson AC, Gilles C, Polette M, Zahm JM, Birembaut P, Tournier JM: Wound repair-induced expression of a stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. Lab Invest 1996, 74:658-669
30. Zahm JM, Kaplan H, Herard AL, Doriot F, Pierrot D, Somelette P, Puchelle E: Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskeleton 1997, 37:33-43[CrossRef][Medline]
31. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450[Abstract/Free Full Text]
32. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S, Lindstrom J: Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 1995, 48:774-782[Abstract]
33. Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, Lindstrom J: Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem 1996, 271:17656-17665[Abstract/Free Full Text]
34. Levandoski MM, Lin Y, Moise L, McLaughlin JT, Cooper E, Hawrot E: Chimeric analysis of a neuronal nicotinic acetylcholine receptor reveals amino acids conferring sensitivity to alpha-bungarotoxin. J Biol Chem 1999, 274:26113-26119[Abstract/Free Full Text]
35. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM: A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J Biol Chem 1996, 271:7522-7528[Abstract/Free Full Text]
36. Harvey SC, McIntosh JM, Cartier GE, Maddox FN, Luetje CW: Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors. Mol Pharmacol 1997, 51:336-342[Abstract/Free Full Text]
37. Grant GA, Luetje CW, Summers R, Xu XL: Differential roles for disulfide bonds in the structural integrity and biological activity of kappa-bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist. Biochemistry 1998, 37:12166-12171[CrossRef][Medline]
38. Martin WR, Brown C, Zhang YJ, Wu R: Growth and differentiation of primary tracheal epithelial cells in culture: regulation by extracellular calcium. J Cell Physiol 1991, 147:138-148[CrossRef][Medline]
39. Mandeville JT, Ghosh RN, Maxfield FR: Intracellular calcium levels correlate with speed and persistent forward motion in migrating neutrophils. Biophys J 1995, 68:1207-1217[Medline]
40. Giannone G, Ronde P, Gaire M, Beaudouin J, Haiech J, Ellenberg J, Takeda K: Calcium rises locally trigger focal adhesion disassembly and enhance residency of focal adhesion kinase at focal adhesions. J Biol Chem 2004, 279:28715-28723[Abstract/Free Full Text]
41. Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Kummer W, Lips K, Vetter DE, Grando SA: Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol 2002, 159:325-336[Abstract/Free Full Text]
42. Nguyen VT, Hall LL, Gallacher G, Ndoye A, Jolkovsky DL, Webber RJ, Buchli R, Grando SA: Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. J Dent Res 2000, 79:939-949[Abstract/Free Full Text]
43. Elias JA, Zhu Z, Chupp G, Homer RJ: Airway remodeling in asthma. J Clin Invest 1999, 104:1001-1006[Medline]
44. Fahy JV: Remodeling of the airway epithelium in asthma. Am J Respir Crit Care Med 2001, 164:S46-S51[Abstract/Free Full Text]
45. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38[Abstract/Free Full Text]
46. Zahm JM, Pierrot D, Chevillard M, Puchelle E: Dynamics of cell movement during the wound repair of human surface respiratory epithelium. Biorheology 1992, 29:459-465[Medline]
47. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ: A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992, 41:31-37[Abstract]
48. James JR, Nordberg A: Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer’s disease and Parkinson’s disease. Behav Genet 1995, 25:149-159[CrossRef][Medline]